HealthTree, in partnership with CorEvitas, is conducting a study for patients who started Talquetamab (TALVEY) therapy less than 4 months ago. 🔒 The information you share will be confidential and de-identified. Your insights can help shape the future of myeloma research and improve care for others. 💙 👉 Ready to join? Click here to read and sign the consent form: https://bit.ly/3DoCJom ✅ Our team will contact you to confirm your eligibility and arrange the interviews. 🙌 Thank you for helping advance myeloma research! #MyelomaResearch #Talquetamab #HealthTree